Friday, January 16, 2026 | 10:48 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aurobindo Pharma Ltd

Curateq Biologics Receives NOC From Health Canada For Its Biosimilar Dyrupeg

03:19 PM, 9th Jan 2026

Intimation of receipt of Notice of Compliance from Health Canada by Curateq Biologics Private Limited a wholly owned subsidiary of the Company for its biosimilar Dyrupeg.

More Aurobindo Pharma Ltd Announcements